These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11301824)

  • 1. Hepatitis vaccines.
    Koff RS
    Infect Dis Clin North Am; 2001 Mar; 15(1):83-95. PubMed ID: 11301824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current issues in the management of paediatric viral hepatitis.
    Yeung LT; Roberts EA
    Liver Int; 2010 Jan; 30(1):5-18. PubMed ID: 19840256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination.
    Diamond C; Thiede H; Perdue T; Secura GM; Valleroy L; Mackellar D; Corey L;
    Sex Transm Dis; 2003 May; 30(5):425-32. PubMed ID: 12916134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis in the Arctic.
    McMahon BJ
    Int J Circumpolar Health; 2004; 63 Suppl 2():41-8. PubMed ID: 15736621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of hepatitis A and hepatitis B with vaccination].
    Buisson Y; Meyran M
    Bull Acad Natl Med; 1995 Feb; 179(2):367-74; discussion 373-5. PubMed ID: 7614064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
    Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
    Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine delivery.
    Hendrickx G; Vorsters A; Van Damme P
    Curr Opin Infect Dis; 2012 Oct; 25(5):578-83. PubMed ID: 22907280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two vaccination strategies against hepatitis A and B in patients with chronic hepatitis C.
    Díez Redondo MP; Almaraz A; Jiménez Rodríguez-Vila M; Santamaría A; de Castro J; Torrego JC; Caro-Patón A
    Rev Esp Enferm Dig; 2009 Apr; 101(4):265-74. PubMed ID: 19492902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twinrix vaccination schedules among injecting drug users.
    Brim N; Zaller N; Taylor LE; Feller E
    Expert Opin Biol Ther; 2007 Mar; 7(3):379-89. PubMed ID: 17309329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against hepatitis viruses in Poland.
    Slusarczyk J
    Vaccine; 2001 Mar; 19(17-19):2384-8. PubMed ID: 11257365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.